paroxetine has been researched along with Acute Disease in 28 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (17.86) | 18.2507 |
2000's | 21 (75.00) | 29.6817 |
2010's | 1 (3.57) | 24.3611 |
2020's | 1 (3.57) | 2.80 |
Authors | Studies |
---|---|
Cornelius, SL; Gui, J; Hoyt, JE; Leonard, CE; Schnurr, PP; Shiner, B; Watts, BV; Young-Xu, Y | 1 |
Berk, M; Dodd, S; Kelin, K; Mancini, M; Schacht, A | 1 |
Chilton, AP; Elias, E; Hubscher, SG; Milkiewicz, P | 1 |
Christensen, J; Clemmensen, PM; Dalsgaard, NJ; Dam, H; Hindberg, I; Lunde, M; Mellerup, E; Plenge, P; Rasmussen, A | 1 |
Akiyoshi, J; Fujiki, M; Horinouchi, Y; Isogawa, K; Kodama, K; Nagayama, H; Tsutsumi, T | 1 |
Keller, MB | 1 |
Allen, A; Burnham, DB; Hollander, E; Oakes, R; Steiner, M; Wheadon, DE | 1 |
Duman, EN; Erciyes, N; Kadioglu, M; Kalyoncu, NI; Kesim, M; Yaris, E | 1 |
Alkin, T; Bandelow, B; Behnke, K; Clary, CM; Goebel, C; Hendriks, GJ; Lenoir, S | 1 |
Hemrick-Luecke, SK; Iyengar, S; Simmons, RM; Webster, AA; Xu, JY | 1 |
Casciano, R; Chen, J; Geissler, EC; Mallick, R; Panish, JM; Trivedi, MH; Wan, GJ | 1 |
Berger, M; Fiebich, BL; Grunze, H; Lieb, K; Normann, C; Walden, J | 1 |
Klemperer, I; Levy, J; Lifshitz, T; Shneck, M; Tessler, Z | 1 |
Chen, YC; Lu, RB; Wu, YS | 1 |
Kang, EH; Kim, KJ; Lee, IS; Yu, BH | 1 |
Barbui, C; Cipriani, A; Furukawa, TA | 1 |
Gasbarrini, G; Mascianà, R; Pompili, M; Rapaccini, GL; Tittoto, P | 1 |
Lundberg, GD | 1 |
Brown, TM; Finkelstein, JA; Magoon, MR; Mareth, TR; Skop, BP | 1 |
DeQuardo, JR; DuBose, C; Lewis, CF; Tandon, R | 1 |
Baumann, P; Bryois, C; Rubin, C; Zbinden, JD | 1 |
Barbone, C; Barsotti, A; Di Girolamo, E; Di Iorio, C; Leonzio, L; Sabatini, P | 1 |
Bennett, HG; Wyllie, AM | 1 |
Boffa, E; Lofchy, J | 1 |
Browning, AC; Chisholm, IH; Nischal, KK; Reck, AC | 1 |
Diehn, F; Tefferi, A | 1 |
Fava, M; Gonzales, JS; Hoog, SL; Judge, RA; Kopp, JB; Nilsson, ME | 1 |
Grunze, H; Hörn, M; Hummel, B; Normann, C; Schärer, LO; Walden, J | 1 |
5 review(s) available for paroxetine and Acute Disease
Article | Year |
---|---|
Treatment response for acute depression is not associated with number of previous episodes: lack of evidence for a clinical staging model for major depressive disorder.
Topics: Acute Disease; Adult; Antidepressive Agents; Citalopram; Cyclohexanols; Depression; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Paroxetine; Recurrence; Thiophenes; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2013 |
Paroxetine treatment of major depressive disorder.
Topics: Acute Disease; Antidepressive Agents, Second-Generation; Anxiety; Depressive Disorder, Major; Humans; Long-Term Care; Paroxetine; Treatment Outcome | 2003 |
Effectiveness of paroxetine in the treatment of acute major depression in adults: a systematic re-examination of published and unpublished data from randomized trials.
Topics: Acute Disease; Depression; Humans; Paroxetine; Patient Compliance; Placebos; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors | 2008 |
[Withdrawal syndrome caused by selective serotonin reuptake inhibitors: apropos of a case].
Topics: Acute Disease; Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Humans; Neurologic Examination; Paroxetine; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome | 1998 |
Pruritus in polycythaemia vera: prevalence, laboratory correlates and management.
Topics: Acute Disease; Erythrocyte Volume; Female; Humans; Leukocyte Count; Male; Middle Aged; Paroxetine; Patient Satisfaction; Polycythemia Vera; Prevalence; Pruritus; Retrospective Studies; Selective Serotonin Reuptake Inhibitors | 2001 |
8 trial(s) available for paroxetine and Acute Disease
Article | Year |
---|---|
Platelet serotonin transporter in stroke patients.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Aspirin; Binding, Competitive; Biomarkers; Blood Platelets; Carrier Proteins; Chronic Disease; Depression; Female; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Paroxetine; Reference Values; Serotonin Plasma Membrane Transport Proteins; Stroke; Time Factors | 2003 |
Acute and long-term treatment and prevention of relapse of obsessive-compulsive disorder with paroxetine.
Topics: Acute Disease; Adolescent; Adult; Aged; Dose-Response Relationship, Drug; Female; Humans; Long-Term Care; Male; Middle Aged; Obsessive-Compulsive Disorder; Paroxetine; Prospective Studies; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2003 |
Sertraline versus paroxetine in the treatment of panic disorder: an acute, double-blind noninferiority comparison.
Topics: Acute Disease; Adult; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Female; Humans; Male; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2004 |
Serum levels of substance P and response to antidepressant pharmacotherapy.
Topics: Acute Disease; Adult; Antidepressive Agents; Depressive Disorder, Major; Humans; Lamotrigine; Paroxetine; Severity of Illness Index; Substance P; Surveys and Questionnaires; Triazines | 2004 |
Venlafaxine vs. paroxetine in the acute phase of treatment for major depressive disorder among Han Chinese population in Taiwan.
Topics: Acute Disease; Adult; Asian People; China; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Paroxetine; Pharmacogenetics; Prospective Studies; Psychiatric Status Rating Scales; Remission Induction; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 2007 |
Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study.
Topics: Acute Disease; Adult; Double-Blind Method; Electrocardiography, Ambulatory; Female; Follow-Up Studies; Humans; Male; Middle Aged; Paroxetine; Refractory Period, Electrophysiological; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Syncope, Vasovagal; Tilt-Table Test; Treatment Outcome | 1999 |
Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia.
Topics: Acute Disease; Adverse Drug Reaction Reporting Systems; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Fluoxetine; Humans; Paroxetine; Personality Inventory; Sertraline; Sleep Initiation and Maintenance Disorders; Treatment Outcome | 2002 |
Lamotrigine as adjunct to paroxetine in acute depression: a placebo-controlled, double-blind study.
Topics: Acute Disease; Adolescent; Adult; Aged; Anticonvulsants; Depressive Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lamotrigine; Male; Middle Aged; Paroxetine; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Triazines | 2002 |
15 other study(ies) available for paroxetine and Acute Disease
Article | Year |
---|---|
Comparing Medications for DSM-5 PTSD in Routine VA Practice.
Topics: Acute Disease; Adult; Carbonic Anhydrase Inhibitors; Female; Fluoxetine; Humans; Male; Medication Adherence; Outcome Assessment, Health Care; Paroxetine; Remission Induction; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; Topiramate; United States; United States Department of Veterans Affairs; Venlafaxine Hydrochloride | 2020 |
Antidepressant induced cholestasis: hepatocellular redistribution of multidrug resistant protein (MRP2).
Topics: Acute Disease; Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Biopsy; Cholestasis; Citalopram; Dothiepin; Female; Humans; Immunohistochemistry; Liver; Male; Middle Aged; Mitochondrial Proteins; Paroxetine; Pregnancy; Pregnancy Complications; Ribosomal Proteins; Saccharomyces cerevisiae Proteins | 2003 |
Anxiety induced by repetitive transcranial magnetic stimulation is suppressed by chronic treatment of paroxetine in rats.
Topics: Acute Disease; Animals; Anxiety; Chronic Disease; Electric Stimulation; Fear; Male; Maze Learning; Motor Activity; Paroxetine; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Transcranial Magnetic Stimulation | 2003 |
Possible involvement of opioidergic and serotonergic mechanisms in antinociceptive effect of paroxetine in acute pain.
Topics: Acute Disease; Analgesics; Animals; Female; Male; Mice; Narcotic Antagonists; Pain; Paroxetine; Receptors, Opioid; Receptors, Serotonin | 2004 |
Efficacy of duloxetine, a potent and balanced serotonin-norepinephrine reuptake inhibitor in persistent pain models in rats.
Topics: Acute Disease; Amines; Amitriptyline; Animals; Conscious Sedation; Cyclohexanecarboxylic Acids; Cyclohexanols; Cyclopropanes; Disease Models, Animal; Drug Therapy, Combination; Duloxetine Hydrochloride; Fluoxetine; Formaldehyde; Gabapentin; gamma-Aminobutyric Acid; Male; Methyltyrosines; Milnacipran; Neuromuscular Junction; Norepinephrine; p-Chloroamphetamine; Pain; Paroxetine; Rats; Rats, Sprague-Dawley; Serotonin; Thiophenes; Venlafaxine Hydrochloride | 2004 |
Cost and effectiveness of venlafaxine extended-release and selective serotonin reuptake inhibitors in the acute phase of outpatient treatment for major depressive disorder.
Topics: Activities of Daily Living; Acute Disease; Ambulatory Care; Cost-Benefit Analysis; Cyclohexanols; Decision Support Techniques; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Drug Costs; Female; Fluoxetine; Fluvoxamine; Humans; Male; Paroxetine; Quality-Adjusted Life Years; Randomized Controlled Trials as Topic; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2004 |
Late bilateral acute angle-closure glaucoma after administration of paroxetine in a patient with plateau iris configuration.
Topics: Acute Disease; Antidepressive Agents, Second-Generation; Depressive Disorder; Female; Glaucoma, Angle-Closure; Humans; Intraocular Pressure; Iris; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Ultrasonography | 2004 |
beta-adrenoceptor affinity as a biological predictor of treatment response to paroxetine in patients with acute panic disorder.
Topics: Acute Disease; Adult; Ambulatory Care; Biomarkers; Control Groups; Cyclic AMP; Female; Humans; Isoproterenol; Lymphocytes; Male; Panic Disorder; Paroxetine; Personality Inventory; Probability; Receptors, Adrenergic, beta; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2008 |
Acute hepatitis associated with use of paroxetine.
Topics: Acute Disease; Aged, 80 and over; Chemical and Drug Induced Liver Injury; Female; Humans; Liver Function Tests; Paroxetine; Selective Serotonin Reuptake Inhibitors | 2008 |
Placebo as good as paroxetine for treating acute moderate-to-severe major depression.
Topics: Acute Disease; Clinical Trials as Topic; Depressive Disorder, Major; Humans; Paroxetine; Placebo Effect; Treatment Outcome | 2008 |
The serotonin syndrome associated with paroxetine, an over-the-counter cold remedy, and vascular disease.
Topics: Acetaminophen; Acute Disease; Akathisia, Drug-Induced; Blood Platelets; Dextromethorphan; Diagnosis, Differential; Doxylamine; Drug Combinations; Drug Interactions; Drug Therapy, Combination; Endothelium, Vascular; Ephedrine; Humans; Hypertension; Male; Middle Aged; Myoclonus; Nonprescription Drugs; Paroxetine; Peripheral Vascular Diseases; Promethazine; Pseudoephedrine; Sweating; Syndrome | 1994 |
Acute angle-closure glaucoma and paroxetine.
Topics: Acute Disease; Aged; Depressive Disorder; Female; Glaucoma, Angle-Closure; Humans; Paroxetine | 1997 |
Paroxetine and acute angle-closure glaucoma.
Topics: Acute Disease; Antidepressive Agents, Second-Generation; Female; Glaucoma, Angle-Closure; Humans; Middle Aged; Paroxetine | 1999 |
Paroxetine and tardive akathisia.
Topics: Acute Disease; Adult; Akathisia, Drug-Induced; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors | 2000 |
Acute angle closure glaucoma presenting in a young patient after administration of paroxetine.
Topics: Acute Disease; Adult; Antidepressive Agents, Second-Generation; Glaucoma, Angle-Closure; Humans; Male; Paroxetine | 2000 |